Citryll is a Biotech company based in Oss, Netherlands. It has raised $128M in total funding. Latest round: Series B.
Citryll funding overview
Citryll is a Biotech company based in Oss, Netherlands. Citryll has raised $128M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for Citryll runs through 2024; nothing later has been disclosed. Investors on record include Johnson & Johnson Innovation - JJDC, Inc., Forbion, Novartis Venture Fund, Pureos Bioventures, BioGeneration Ventures, Seventure Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Citryll at a glance
Total raised
$128M
Latest round
Series B
Latest round date
December 2024
Industry
Biotech
Headquarters
Oss, Netherlands
Notable investors
Johnson & Johnson Innovation - JJDC, Inc., Forbion, Novartis Venture Fund, Pureos Bioventures, BioGeneration Ventures, Seventure Partners, BOM, Curie Capital
Frequently asked about Citryll funding
How much has Citryll raised?
Citryll has raised $128M in total disclosed funding across the rounds on record.
Who has invested in Citryll?
Johnson & Johnson Innovation - JJDC, Inc., Forbion, Novartis Venture Fund, Pureos Bioventures, BioGeneration Ventures, Seventure Partners are named among the investors backing Citryll.
What was the latest Citryll funding round?
The most recent disclosed round is a Series B, announced in December 2024.
Where is Citryll based?
Citryll is based in Oss, Netherlands.
What sector does Citryll operate in?
Citryll is tracked under Biotech from Oss, Netherlands, with $128M in disclosed funding.
When did Citryll last raise?
The last disclosed Citryll round closed in December 2024 at Series B.
Round data for Citryll is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Oss and backer lists below.
